James Hildreth told NBC Dec. 5 that the agency will spend Dec. 10 reviewing Pfizer’s data and will vote at the end of the day. Distribution of the vaccine could begin the next day.
“If the FDA commissioner decides to issue approval, the EUA, on that day when the vote is taken, as early as Friday of next week, we could see vaccinations happening across the country,” he added, according to The Hill.
Pfizer’s data from phase 3 trials has shown the vaccine to be 95 percent effective at preventing COVID-19 infection.
The CDC voted last week to decide that healthcare workers and residents of long-term care facilities should get the vaccine first.
More articles on pharmacy:
CVS Health to help administer Eli LIlly’s COVID-19 antibody drug
Obama, Bush, Clinton say they would televise their COVID-19 vaccinations to boost public trust
WHO’s decision to reject remdesivir based on flawed study, health experts say
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
